Japanese Mergers Provide Opening For Biotech Deals – Novartis Licensing Head
This article was originally published in The Pink Sheet Daily
Executive Summary
But multinationals may be increasingly squeezed out of Japanese deals due to the merger wave, company exec tells BIO-Asia conference in Tokyo.